SIA
BIIB icon

Schechter Investment Advisors’s Biogen BIIB Stock Holding History

Schechter Investment Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,592
Closed -$382K – 935
2021
Q4 		$382K Buy
+1,592
New +$409K 0.03% 595

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Schechter Investment Advisors's BIIB Position: Q1 2022 in Review

Schechter Investment Advisors sold out of Biogen (BIIB) in Q1 2022, closing a stake of 1,592 shares — an estimated $382K sold.

Schechter Investment Advisors first reported a position in BIIB in Q4 2021 and held it in 1 quarter. The position peaked at $382K in Q4 2021. 952 funds tracked by Wall St. Rank hold BIIB as of Q1 2022.

  • Schechter Investment Advisors reported no remaining Biogen position as of Q1 2022 after selling out during the quarter.
  • Schechter Investment Advisors sold 1,592 Biogen shares in Q1 2022, an estimated $382K.
  • Schechter Investment Advisors first reported a position in Biogen in Q4 2021 and held it in 1 quarter.
  • Schechter Investment Advisors's Biogen position peaked at $382K in Q4 2021.
  • 952 funds tracked by Wall St. Rank held Biogen as of Q1 2022.

Based on Schechter Investment Advisors's 13F filing for Q1 2022, filed 18 Nov 2022.